Cellyan Biotechnology Co Ltd Class A HKPD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.11
- Day Range
- $0.10–0.11
- 52-Week Range
- $0.10–1.72
- Bid/Ask
- $0.10 / $0.12
- Shares Outstanding
- 49.32M
- Market Cap
- $5.43M
- Volume/Avg
- 266,244 / 4M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.13
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 11
- Website
- http://www.9zt.hk
Valuation
|
Metric
|
HKPD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.27 |
Price/Sales | 0.13 |
Price/Cash Flow | — |
Price/Earnings
HKPD
Financial Strength
|
Metric
|
HKPD
|
|---|---|
Quick Ratio | 1.71 |
Current Ratio | 3.86 |
Interest Coverage | −7.43 |
Quick Ratio
HKPD
Profitability
|
Metric
|
HKPD
|
|---|---|
Return on Assets (Normalized) | −11.84% |
Return on Equity (Normalized) | −19.16% |
Return on Invested Capital (Normalized) | −13.18% |
Return on Assets
HKPD
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|#sv>VY | LOCK|Llt&g | $117B | |||
| Cencora Inc
COR
| LOCK|ZX>#FtY | LOCK|RqlD | $65B | |||
| Cardinal Health Inc
CAH
| LOCK|gf>!qC | LOCK|p^b?C | $59B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|z?tC | $23B | |||
| Henry Schein Inc
HSIC
| LOCK|C??HpM& | LOCK|?vW^l | $10B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|Kfp | $8B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|lW | $6B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|M?W | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|vRSQs | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|K% | $4B |
United States